Sunscreens and sun protection

Cancer Treatment and Research

Volumn 146, Issue , 2009, Pages 425-432

  Fallon, Jason ^a   Murphy, Gillian M ^b  

^a BEAUMONT HOSPITAL   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETABOLITE; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; SUNSCREEN; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADVERSE OUTCOME; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; DRUG EFFICACY; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MELANOMA; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SKIN COLOR; SKIN PROTECTION; SUN EXPOSURE; SUNBURN; ULTRAVIOLET RADIATION; GENETIC PREDISPOSITION; LIGHT; ORGAN TRANSPLANTATION; SKIN NEOPLASMS; SUNLIGHT;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LIGHT; ORGAN TRANSPLANTATION; SKIN NEOPLASMS; SUNLIGHT; SUNSCREENING AGENTS; ULTRAVIOLET RAYS;

EID: 77953672788     PISSN: 09273042     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78574-5_34     Document Type: Review

References (41)

1. www.who.int/mediacentre/factsheets/fs271/en/
2. www.who.int/mediacentre/factsheets/fs261/en/
3. Diamond J. Evolutionary biology: geography and skin colour. Nature 2005; 435(7040):283-4.
4. Neer RM. The evolutionary significance of vitamin D, skin pigment, and ultraviolet light. Am J Phys Anthropol 1975; 43(3):409-16.
5. Branda RF, Eaton JW. Skin color and nutrient photolysis: an evolutionary hypothesis. Science 1978; 201(4356):625-6.
6. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124(6):869-71.
7. Rees JL. The genetics of sun sensitivity in humans. Am J Hum Genet 2004; 75(5):739-51.
8. Han J, Kraft P, Colditz GA, et al. Melanocortin 1 receptor variants and skin cancer risk. Int J Cancer 2006; 119(8):1976-84.
9. Moloney FJ, Comber H, O'Lorcain P, et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006; 154(3):498-504.
10. Moloney FJ, de Freitas D, Conlon PJ, et al. Renal transplantation, immunosuppression and the skin: an update. Photodermatol Photoimmunol Photomed 2005; 21(1):1-8.
11. Karagas MR, Nelson HH, Sehr P, et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 2006; 98(6):389-95.
12. Struijk L, Hall L, van der Meijden E, et al. Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2006; 15(3):529-35.
13. O'Connor DP, Kay EW, Leader M, et al. Altered p53 expression in benign and malignant skin lesions from renal transplant recipients and immunocompetent patients with skin cancer: correlation with human papillomaviruses? Diagn Mol Pathol 2001; 10(3):190-9.
14. O'Connor DP, Kay EW, Leader M, et al. p53 codon 72 polymorphism and human papillomavirus associated skin cancer. J Clin Pathol 2001; 54(7):539-42.
15. O'Connor DP, Kay EW, Leader M, et al. A high degree of chromosomal instability at 13q14 in cutaneous squamous cell carcinomas: indication for a role of a tumour suppressor gene other than Rb. Mol Pathol 2001; 54(3):165-9.
16. Giampieri S, Storey A. Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from human papillomaviruses types 5 and 18. Br J Cancer 2004; 90(11):2203-9.
17. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348(17):1681-91.
18. Moloney FJ, Collins S, Murphy GM. Sunscreens: safety, efficacy and appropriate use. Am J Clin Dermatol 2002; 3(3):185-91. Review. Photochem Photobiol 1995; 61(6):615-8.
19. Diffey BL, Saunders PJ. Behaviour outdoors and its effects on personal ultraviolet exposure rate measured using an ambulatory datalogging dosimeter. Photochem Photobiol 1995; 61(6):615-8.
20. Gies HP, Roy CR, McLennan A, et al. UV protection by clothing: an intercomparison of measurements and methods. Health Phys 1997; 73(3):456-64.
21. Thieden E, Collins SM, Philipsen PA, et al. Ultraviolet exposure patterns of Irish and Danish gardeners during work and leisure. Br J Dermatol 2005; 153(4):795-801.
22. Diffey BL, Diffey JL. Sun protection with trees. Br J Dermatol 2002; 147(2):397-9.
23. Urbach F. The historical aspects of sunscreens. J Photochem Photobiol B 2001; 64:99-104.
24. Nash JF. Human safety and efficacy of ultraviolet filters and sunscreen products. Dermatol Clin 2006; 24(1):35-51.
25. The European Cosmetic, Toiletry and Perfumery Association (COLIPA) International Sun Protection Factor (SPF) Test Method. Brussels: The European Cosmetic, Toiletry, and Perfumery Association, 2003.
26. Diffey BL, Tanner PR, Matts PJ, et al. In vitro assessment of the broad-spectrum ultraviolet protection of sunscreen products. J Am Acad Dermatol 2000; 43(6):1024-35.
27. Cole C. Sunscreen protection in the ultraviolet A region: how to measure the effectiveness. Photodermatol Photoimmunol Photomed 2001; 17(1):2-10.
28. U.S. Food and Drugs Administration. The Final Over-the-Counter Drug Monograph on Sunscreens (Federal Register 1999; 64:27666-27963). http://www.fda.gov/ohrms/dockets/ 98fr/052199b.pdf
29. European Commission Cosmetic Directive. Annex VII: List of permitted UV filters which cosmetic products may contain. From: The Council Directive on the approximation of the laws of the Member States relating to cosmetic products 76/768/EEC. Official Jo L 2005 update (pp 102-108). http://europa.eu.int/eurlex/ lex/LexUriServ/site/en/ consleg/1976/L/01976L0768-20050913-en.pdf:
30. Nohynek GJ, Schaefer H. Benefit and risk of organic ultraviolet filters. Regul Toxicol Pharmacol 2001; 33(3):285-99.
31. European Commission. Commission Decision of 8 May 1996 establishing an inventory and a common nomenclature of ingredients employed in cosmetic products 96/335/EC84. Official Jo L 1996; 132:1-684. http://ec.europa.eu/enterprise/ cosmetics/inci/inci 2006.pdf
32. US Food and Drugs Administration. Sunscreen Drug Products for Human Use. Centre for Devices and Radiological Health Part 352. Fed Reg 67(No. 119), 2002. http://www. accessdata. fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart= 352&showFR=1
33. IARC. Handbooks on Cancer Prevention, vol 5. Lyon: IARC Press, 2001.
34. Darlington S, Williams G, Neale R, et al. A randomized controlled trial to assess sunscreen application and betacarotene supplementation in the prevention of solar keratoses. Arch Dermatol 2003; 139(4):451-5.
35. Green A, Williams G, Neale R, et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 1999; 354(9180):723-9. Erratum in: Lancet 1999; 354(9183):1038.
36. Moloney FJ, Almarzouqi E, O'Kelly P, et al. Sunscreen use before and after transplantation and assessment of risk factors associated with skin cancer development in renal transplant recipients. Arch Dermatol 2005; 141(8):978-82.
37. Moloney FJ, Comber H, Conlon PJ, et al. The role of immunosuppression in the pathogenesis of basal cell carcinoma. Br J Dermatol 2006; 154(4):790-1.
38. Laing ME, Moloney FJ, Comber H, et al. Malignant melanoma in renal transplant recipients. Br J Dermatol 2006; 155(4):857.
39. Laing ME, Moloney FJ, Kay EW, et al. Malignant melanoma in transplant patients: review of five cases. Clin Exp Dermatol 2006; 31(5):662-4.
40. D'Orazio JA, Nobuhisa T, Cui R, et al. Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning. Nature 2006; 443(7109):340-4.
41. Barnetson RSC, Ooi TKT, Zhuang L, et al. [Nle4-D-Phe7] - Melanocyte-Stimulating Hormone Significantly Increased Pigmentation and Decreased UV Damage in Fair-Skinned Caucasian Volunteers. J Invest Dermat 2006; 126:1869-78.